Ritu Salani - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Ritu Salani's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Ritu Salani
Verified
Contributor, Cancer Network
Columbus
Beats
Products, partnerships, self-reported surveys
Content
By Ritu Salani| OncLive Verified CommentaryVideoMarch 11, 2025Author(s):Fact checked by:Ritu Salani, MD, MBA, discusses considerations in clinical trial design and the evolving role of HER2-targeted ADCs in gynecologic malignancies. "We need to think outside the box a little bit.
By Ritu Salani| CURE Magazine Verified Dr. Ritu Salani, a board-certified gynecologic oncologist and the Director of Gynecologic Oncology at the University of California, Los Angeles (UCLA), UCLA Health, sat down for an interview with CURE on the topic of cervical cancer.
By Ritu Salani| OncLive Verified CommentaryVideoMarch 11, 2025Author(s):Fact checked by:Ritu Salani, MD, MBA, discusses considerations in clinical trial design and the evolving role of HER2-targeted ADCs in gynecologic malignancies. "We need to think outside the box a little bit.
Company Info
Cancer Network
Cancer Network is an online platform focused on providing oncology news and clinical expertise. It serves as a valuable resource for insights on cancer screening, early detection, diagnosis, treatment, and prevention. The platform hosts the journal *Oncology*, which delivers professional content aimed at healthcare providers involved in cancer care. As a comprehensive information hub, Cancer Network offers timely updates on advances in cancer research, treatment modalities, and clinical trials. It features articles and expert commentary on best practices in oncology care, along with educational resources that help healthcare providers stay informed about the latest developments in cancer management. The primary audience includes oncologists, oncology nurses, researchers, and other healthcare professionals seeking authoritative information to enhance patient outcomes.
'+1 516-562-5000